Can The Daily Beast Claw Its Way Back to Relevance?
Read more at The New York Times
-
3 ways you can push back against election misinformation
Politics - The Hill - October 19 -
In a Tight Presidential Race, Omaha Is Basking in Its Political Relevance
Top stories - The New York Times - October 23 -
3 Things You Can Do to Stay Relevant as AI Alters the Workplace
Business - Inc. - October 26 -
This Simple Strategy Can Get People Talking About You Behind Your Back (in a Good Way)
Business - Inc. - October 25 -
Can Boeing come back?
Business - Financial Times - 6 days ago -
NYSE plans to extend daily trading to 22 hours on its Arca exchange
Business - Financial Times - October 25 -
Tehran goes about its daily routine despite overnight Israeli attack
World - Yahoo News - October 26 -
How Volkswagen Lost Its Way in China
Business - The New York Times - 4 days ago -
Crowds at the Row’s Sample Sale Beg a Question: Can It Stay Cool?
Lifestyle - The New York Times - October 25
More from The New York Times
-
Right-Wing Groups Are Organizing on Telegram Ahead of Election Day
Business - The New York Times - 8 hours ago -
Foreclosures in China Soar, Threatening to Choke Off Bank Profits
Business - The New York Times - 17 hours ago -
How Elon Musk’s X Account Dominates the Platform Ahead of the Election
Business - The New York Times - Yesterday -
Nobody Likes Doing Expense Reports. Why Isn’t It Easier?
Business - The New York Times - Yesterday -
New York Times Passes 11 Million Subscribers
Business - The New York Times - 8 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 59 minutes ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago